These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8370476)

  • 21. Rat aortic allografts: an experimental model for chronic transplant arteriosclerosis.
    Häyry P; Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):611-2. PubMed ID: 1990624
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of 15-deoxyspergualin on allograft arterio-sclerosis and growth factor synthesis in the rat.
    Räisänen-Sokolowski A; Aho P; Tufveson G; Häyry P
    Transpl Int; 1994; 7 Suppl 1():S376-7. PubMed ID: 11271256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental transplant arteriosclerosis: inhibition by angiopeptin and low molecular weight heparin derivatives.
    Akyürek ML; Larsson E; Funa K; Wanders A; Kaijser M; Fellström BC
    Transplant Proc; 1995 Dec; 27(6):3555-6. PubMed ID: 8540099
    [No Abstract]   [Full Text] [Related]  

  • 24. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor.
    Mohacsi PJ; Tüller D; Hulliger B; Wijngaard PL
    J Heart Lung Transplant; 1997 May; 16(5):484-92. PubMed ID: 9171265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide inhibition of myointimal proliferation by angiopeptin, a somatostatin analogue.
    Lundergan CF; Foegh ML; Ramwell PW
    J Am Coll Cardiol; 1991 May; 17(6 Suppl B):132B-136B. PubMed ID: 1673136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats.
    Onuta G; Rienstra H; de Boer JF; Boer MW; Roks AJ; Klatter FA; Uges DR; Navis G; Rozing J; Hillebrands JL
    Transplantation; 2007 Aug; 84(4):517-26. PubMed ID: 17713437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A20-mediated modulation of inflammatory and immune responses in aortic allografts and development of transplant arteriosclerosis.
    Siracuse JJ; Fisher MD; da Silva CG; Peterson CR; Csizmadia E; Moll HP; Damrauer SM; Studer P; Choi LY; Essayagh S; Kaczmarek E; Maccariello ER; Lee A; Daniel S; Ferran C
    Transplantation; 2012 Feb; 93(4):373-82. PubMed ID: 22245872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts.
    Räisänen-Sokolowski A; Vuoristo P; Myllärniemi M; Yilmaz S; Kallio E; Häyry P
    Transpl Immunol; 1995 Dec; 3(4):342-51. PubMed ID: 8665154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of A20 in the vessel wall of rat-kidney allografts correlates with protection from transplant arteriosclerosis.
    Kunter U; Floege J; von Jürgensonn AS; Stojanovic T; Merkel S; Gröne HJ; Ferran C
    Transplantation; 2003 Jan; 75(1):3-9. PubMed ID: 12544863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ischemia induced upregulation of growth factor expression in experimental transplant arteriosclerosis.
    Fellström B; Akyürek ML; Larsson F; Waltenberger J; Wanders A; Funa K
    Transplant Proc; 1997 Sep; 29(6):2558. PubMed ID: 9290739
    [No Abstract]   [Full Text] [Related]  

  • 31. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
    Koskinen PK; Lemström KB; Häyry PJ
    Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of effect of recombinant human superoxide dismutase on cold ischemia-induced arteriosclerosis in syngeneic rat aortic transplants.
    Myllärniemi M; Räisänen-Sokolowski A; Vuoristo P; Kallio E; Land W; Häyry P
    Transplantation; 1996 Apr; 61(7):1018-22. PubMed ID: 8623179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin and BIM 23034.
    Lundergan C; Foegh ML; Vargas R; Eufemio M; Bormes GW; Kot PA; Ramwell PW
    Atherosclerosis; 1989 Nov; 80(1):49-55. PubMed ID: 2574977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The origin of neointimal smooth muscle cells in transplant arteriosclerosis from recipient bone-marrow cells in rat aortic allograft.
    Song Z; Li W; Zheng Q; Shang D; Shu X; Guan S
    J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):303-6. PubMed ID: 17641848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic rejection.
    Koskinen P; Lemström K; Häyry P
    Curr Opin Nephrol Hypertens; 1996 May; 5(3):269-72. PubMed ID: 8737863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral Platelet-Derived Growth Factor and Vascular Endothelial Growth Factor Inhibitor Sunitinib Prevents Chronic Allograft Injury in Experimental Kidney Transplantation Model.
    Rintala JM; Savikko J; Palin N; Rintala SE; Koskinen PK; von Willebrand E
    Transplantation; 2016 Jan; 100(1):103-10. PubMed ID: 26262503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of aortic graft arteriosclerosis by systemic administration of Allotrap peptide RDP58.
    Li W; Iyer S; Lu L; Buelow R; Fung JJ; Rao AS; Woo J; Qian S
    Transpl Int; 2003 Dec; 16(12):849-56. PubMed ID: 12942166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic rejection of rat aortic allograft. II. Administration of cyclosporin induces accelerated allograft arteriosclerosis.
    Mennander A; Tiisala S; Paavonen T; Halttunen J; Häyry P
    Transpl Int; 1991 Sep; 4(3):173-9. PubMed ID: 1958283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of ischemia time on chronic vascular rejection in the rat--effects of angiopeptin.
    Wanders A; Akyürek ML; Waltenberger J; Stafberg C; Larsson E; Zhiping R; Funa K; Fellström B
    Transplant Proc; 1993 Apr; 25(2):2098-9. PubMed ID: 8097069
    [No Abstract]   [Full Text] [Related]  

  • 40. Lanreotide, a somatostatin analogue, reduces insulin-like growth factor I accumulation in proliferating aortic tissue in rabbits in vivo. A preliminary study.
    Howell M; Orskov H; Frystyk J; Flyvbjerg A; Grønbaek H; Foegh M
    Eur J Endocrinol; 1994 Apr; 130(4):422-5. PubMed ID: 8162175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.